Alkem Labs Shares Decline Nearly 5% Following CEO Resignation

Alkem Laboratories Shares Decline Sharply Following CEO's Resignation

Alkem Laboratories shares took a significant hit on Friday, with the stock plummeting nearly 5 percent in late afternoon trade. The company's shares were trading at Rs 5,261, a decline of 4.7 percent. This comes as a surprise, given that the stock has remained largely flat over the past one year, with a marginal decline of only 1.5 percent in the Nifty 50.

The decline in the stock can be attributed to the news of Vikas Gupta's resignation as the Chief Executive Officer of Alkem Laboratories. The company informed exchanges that Gupta has resigned from his position to pursue new professional opportunities. Gupta will continue in his role until June 30, 2026, to ensure a smooth transition of responsibilities.

In his resignation letter, Gupta highlighted the company's progress in strengthening its market position and advancing its R&D pipeline. He expressed his gratitude for the opportunity to lead the company and acknowledged the dedication of the team. Gupta's resignation letter also emphasized his commitment to supporting the management during the transition period.

Read also: BMTC, Namma Metro Integration: Single Card Payment System to Launch in June

The company's market capitalisation stands at over Rs 63,000 crore, indicating a significant presence in the pharmaceutical industry. Alkem Laboratories' decision to announce Gupta's resignation and provide a smooth transition period suggests a commitment to maintaining business continuity.